Labcorp (LH) Stock Price & Analysis

LH$367.79—
Medical - Diagnostics & ResearchLarge Cap
Compare
Market cap$29.81BEnterprise value—Revenue (TTM)$14.59BMarket positionTop 25%

Score

40
Bearish
Value
36
Quality
47
Growth
38

AI Analysis

Snapshot

Labcorp Holdings doesn’t screen as a clean setup today — Stocklytics 40/100 leaves more to prove. Under the hood: P/E 30.0, rich vs its own history, plus revenue compounding ~6% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

36
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

38
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

47
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Labcorp Holdings Inc. (LH) last printed $367.79. Equity value is $29.81B. Trailing earnings multiple 29.83. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$9.64B$10.44B$11.33B$11.55B$13.98B$13.14B$11.86B$12.16B$13.01B$13.95B

About

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Labcorp (LH) Stock Price & Analysis

LH price $367.79 —

Ticker
LH
Price
$367.79
Change
—
Market cap
$29.81B
P/E
29.83
Forward P/E
19.16
Dividend yield
0.78%
Beta
0.84
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
40
Value
36
Quality
47
Growth
38

Stocklytics score rationale: value 36, quality 47, growth 38.

AI Score 75. Labcorp Holdings Inc. has a market cap of $29.3 billion and a price of $361.39, with a price-to-earnings ratio of 29.5, indicating a premium valuation

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener